rosiglitazone has been researched along with Hypertrophy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Fryklund, C; Morén, B; Neuhaus, M; Periwal, V; Stenkula, KG | 1 |
| Carvalho, VF; E Silva, PM; Magalhães, NS; Martins, MA; Torres, RC | 1 |
| Aguila, MB; D'Oliveira Silva, G; de Carvalho, JJ; Mandarim-De-Lacerda, CA; Torres, TS | 1 |
| D'hooge, J; Gallacher, DJ; Hemmeryckx, B; Himmelreich, U; Hoylaerts, MF; Lijnen, HR; Rong Lu, H; Swinnen, M | 1 |
| Gardner, DG; Liang, F; Wang, F; Zhang, S | 1 |
| Bell, D; McDermott, BJ | 1 |
| Kenyon, CJ; Livingstone, DE; Walker, BR | 1 |
7 other study(ies) available for rosiglitazone and Hypertrophy
| Article | Year |
|---|---|
Rosiglitazone treatment enhances intracellular actin dynamics and glucose transport in hypertrophic adipocytes.
Topics: Actins; Adipocytes; Animals; Glucose; Hyperplasia; Hypertrophy; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2022 |
Activation of PPAR-γ reduces HPA axis activity in diabetic rats by up-regulating PI3K expression.
Topics: Adrenocorticotropic Hormone; Animals; Cell Count; Corticosterone; Diabetes Mellitus, Experimental; Down-Regulation; Hypertrophy; Hypothalamo-Hypophyseal System; Male; Phosphatidylinositol 3-Kinases; Pituitary-Adrenal System; PPAR gamma; Pro-Opiomelanocortin; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2016 |
Effects of rosiglitazone (a peroxysome proliferator-activated receptor gamma agonist) on the blood pressure and aortic structure in metabolically programmed (perinatal low protein) rats.
Topics: Animals; Aorta; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Diet, Protein-Restricted; Disease Models, Animal; Elasticity; Female; Hypertension; Hypertrophy; Insulin; Leptin; Male; Nitric Oxide Synthase Type III; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Rosiglitazone; Thiazolidinediones; Tunica Media | 2008 |
Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice?
Topics: Adiposity; Animals; Diabetes Mellitus; Genotype; Heart; Heterozygote; Hypertrophy; Male; Mice; Rosiglitazone; Thiazolidinediones | 2013 |
Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
Topics: Animals; Animals, Newborn; Base Sequence; Cell Size; Cells, Cultured; Fenofibrate; Gene Expression; Heart Ventricles; Hypertrophy; Hypoglycemic Agents; Hypolipidemic Agents; Ligands; Molecular Sequence Data; Mutagenesis, Site-Directed; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peroxisome Proliferators; Pyrimidines; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sarcomeres; Thiazoles; Thiazolidinediones; Transcription Factors | 2003 |
Effects of rosiglitazone and interactions with growth-regulating factors in ventricular cell hypertrophy.
Topics: Animals; Cell Survival; Cells, Cultured; Culture Media; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Interactions; Endothelin-1; Glucose; Heart Ventricles; Hypertrophy; Insulin; Insulin-Like Growth Factor I; Isoproterenol; Male; Myocytes, Cardiac; Norepinephrine; Phenylalanine; Rats; Rats, Sprague-Dawley; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones | 2005 |
Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adipose Tissue; Adrenal Glands; Adrenalectomy; Analysis of Variance; Animals; Blood Glucose; Corticosterone; Eating; Hydroxysteroid Dehydrogenases; Hypertrophy; Hypoglycemic Agents; Insulin; Liver; Male; Metformin; Obesity; Omentum; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Weight Gain | 2000 |